Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells
- 1 May 1996
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 61 (2) , 182-193
- https://doi.org/10.1002/(sici)1097-4644(19960501)61:2<182::aid-jcb3>3.0.co;2-q
Abstract
Glucocorticoids have been shown to induce the differentiation of bone marrow stromal osteoprogenitor cells into osteoblasts and the mineralization of the matrix. Since the expression of bone matrix proteins is closely related to the differentiation status of osteoblasts and because matrix proteins may play important roles in the mineralization process, we investigated the effects of dexamethasone (Dex) on the expression of bone matrix proteins in cultured normal human bone marrow stromal cells (HBMSC). Treatment of HBMSC with Dex for 23 days resulted in a significant increase in alkaline phosphatase activity with maximum values attained on day 20 at which time the cell matrix was mineralized. Northern blot analysis revealed an increase in the steady‐state mRNA level of alkaline phosphatase over 4 weeks of Dex exposure period. The observed increase in the alkaline phosphatase mRNA was effective at a Dex concentration as low as 10−10 M with maximum values achieved at 10−8 M. In contrast, Dex decreased the steady‐state mRNA levels of both bone sialoprotein (BSP) and osteopontin (OPN) over a 4 week observation period when compared to the corresponding control values. The relative BSP and OPN mRNA levels among the Dex treated cultures, however, showed a steady increase after more than 1 week exposure. The expression of osteocalcin mRNA which was decreased after 1 day Dex exposure was undetectable 4 days later. Neither control nor Dex‐treated HBMSC secreted osteocalcin into the conditioned media in the absence of 1,25(OH)2D3 during a 25‐day observation period. The accumulated data indicate that Dex has profound and varied effects on the expression of matrix proteins produced by human bone marrow stromal cells. With the induced increment in alkaline phosphatase correlating with the mineralization effects of Dex, the observed concomitant decrease in osteopontin and bone sialoprotein mRNA levels and the associated decline of osteocalcin are consistent with the hypothesis that the regulation of the expression of these highly negatively charged proteins is essential in order to maximize the Dex‐induced mineralization process conditioned by normal human bone marrow stromal osteoprogenitor cells.Keywords
This publication has 51 references indexed in Scilit:
- Characterization of the Human Bone SialoProtein (BSP) Gene and its Promoter SequenceMatrix Biology, 1994
- Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genesJournal of Cellular Biochemistry, 1992
- Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation In VitroJournal of Cellular Physiology, 1992
- Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotypeJournal of Cellular Physiology, 1991
- Bone cell differentiation: A functionally coupled relationship between expression of cell-growth- and tissue-specific genesCurrent Opinion in Cell Biology, 1990
- Developmental appearance and ultrastructural immunolocalization of a major 66 kDa phosphoprotein in embryonic and post‐natal chicken boneThe Anatomical Record, 1990
- Regulation of bone sialoprotein mRNA by steroid hormones.The Journal of cell biology, 1989
- Sulphation of secreted phosphoprotein I (SPPI, osteopontin) is associated with mineralized tissue formationBiochemical and Biophysical Research Communications, 1989
- Tissue specificity and developmental expression of rat osteopontinBiochemical and Biophysical Research Communications, 1987
- Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implantsCell Differentiation, 1987